UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

Tag: therapeutics

PROTAC drug discovery – prior preparation and planning

“By failing to prepare, you are preparing to fail” so said Benjamin Franklin, and as a veteran of early stage drug discovery you can bet that I, like you, have seen my fair share of successes but also more failures than I’d like.  

Read More

Lifestyle Interventions in NASH – Backbone, Therapy or Waste of Time?

The effects of lifestyle interventions as a baseline therapy for the treatment of NASH are well accepted. However, there is a high degree of frustration when it comes to recommending and implementing lifestyle changes. Large interventional studies in the field of metabolic disease are largely negative with regards to long-term outcomes.

Read More

Engineering the Microbiome – the Next Frontier

Microbial ecology, our understanding of what determines the robustness and community dynamics of microbial consortia, and synthetic biology, the art of engineering microorganisms to perform particular physiological or metabolic functions, are rapidly becoming allies in the race to develop novel therapeutic strategies in the microbiome space.

Read More

Is the Medical World Ready for Faecal Transplantation as a Therapeutic Option?

The gut microbiota has become a favourite “organ” of the biomedical community, with the number of publications on different aspects of its architecture and function rising exponentially in the last few years. In part fuelled by advances in DNA sequencing technology, multiple studies have been conducted in patients with gastrointestinal (GI) related diseases (IBD, Coeliac, etc.) (1, 2).

Read More

Cross-Cultural Research into Microbiome Therapeutics for Cancer

While microbiome therapeutics to support healthy gut function have garnered the lion’s share of attention, exciting approaches to oncology and anti-inflammatory therapeutics presage a new golden age for drug development, akin to the early commercialisation of chemically synthesised antibiotics from soil biofilms in the mid-20th century.

Read More

Translating Skin Microbiome Research into Clinical Products

Collaboration between academia and industry

It has been demonstrated many times in the past that academia and industry, working in tandem, can achieve results to their mutual benefit much faster than when they work in isolation. However, one critical challenge for academic researchers is finding the right partner to commercialise their technology.

Read More

Links Between Obesity and the Gut Microbiome: What do They Mean for Therapeutics?

Obesity affects 600 million people globally, but the range of available treatments is limited. Recent findings that demonstrate a relationship between the gut microbiome and obesity have brought new hope that bacteria-based therapeutics might offer novel treatments.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive